ERICA MONTECALVO: Open Payments
NPI 1215441753 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,851 in 76 payments from 16 companies in 2025. Trend: 2023 $597 · 2024 $1,502 · 2025 $1,851
Food & beverage: $1,851
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $461 |
| UCB, Inc. | 11 | $264 |
| E.R. Squibb & Sons, L.L.C. | 10 | $242 |
| Amgen Inc. | 9 | $200 |
| Novartis Pharmaceuticals Corporation | 7 | $147 |
| GlaxoSmithKline, LLC. | 1 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Janssen Biotech, Inc. | 2 | $59 |
| Aurinia Pharma U.S., Inc. | 2 | $57 |
| Madrigal Pharmaceuticals | 2 | $47 |
Products named: Bimzelx, SKYRIZI, ORENCIA, RINVOQ, COSENTYX, BENLYSTA, SAPHNELO, EVENITY.
Industry payments across FL — which companies pay providers there.
